Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 24561
Event :Map 2017 : Molecular Analysis For Personalised Therapy

Dates :Friday October 13th, 2017 - Saturday October 14th, 2017

Schulstrasse 44
8050 Zurich, Switzerland

Type :Congress - International audience

Accreditation :12 crédits


Further information

On October 13 – 14 we will be in Zurich, Switzerland to discuss the clinical interpretation of molecular tests for metastatic cancers, alongside medical oncologists, researchers, onco-geneticians, clinical investigators, molecular biologists, cytopathologists, radiotherapists, fellow, academics, regulators and Industry R&D representatives.

Given the rapid increase in targeted therapies now available, we anticipate attendees and speakers at the third MAP Conference will propel ideas and broker new discussions on how to interpret genomic data in precision medicine.

Over two days, world-renowned medical and health professionals will present findings on various topics related to personalised cancer therapy. These discussions are important to help diminish the major gap between our understanding of cancer biology and our evolving approach to patient management.

Topics for this year include:

 • Macroevolution and impact on treatment resistance
 • New models and technologies for personalised medicine
 • Personalised medicine applied to immunotherapeutics
 • Therapeutic targets in cancer
 • Treatment advances in central nervous system tumours
 • Tumour microenvironment and treatment resistance
 • Understanding the broader tumour microenvironment
 • What’s new in the field of clinical trials?

A joint initiative of ESMO, UNICANCER and Cancer Research UK, this conference shines a light on the latest medical developments in a constantly evolving field.


The best abstracts submitted for MAP 2017 will be selected to present their findings during the sessions at the conference.

New to MAP 2017: accepted abstracts will be edited in the "Annals of Oncology" journal.


Accreditation of MAP 2017 will be announced soon.

The MAP 2016 edition was accredited 12 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).







Map and directions
Congress address :
Schulstrasse 44
8050 Zurich
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama


Map 2017 : Molecular Analysis For Personalised Therapy Oncology - Cancerology - Hematology - Immunology
cancer research, unicancer, esmo, molecular analysis, personalised therapy, genome, oncology, metastatic
450 30 10


For more information on Map 2017 : Molecular Analysis For Personalised Therapy, plsase contactr Overcome

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama

Recommend this event